数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
To investigate the effects of moxibustion (MOX) on bone loss and osteogenic differentiation in ovariectomized (OVX) rats and determine whether these effects are mediated by mitophagy through bone marrow mesenchymal stem cells (BMSCs)-derived exosomal miR-27a-3p.
方法
The study was conducted in three stages.
核心结论
In stage 1, sham-operated (SO), OVX, and OVX + MOX rats were evaluated by micro-computed tomography (micro-CT) to assess bone mass and by Alizarin Red S (ARS) staining to evaluate osteogenic differentiation.；Autophagy-related markers were also examined, and mitochondrial-lysosomal colocalization was assessed by immunofluorescence.；In stage 2, the mitophagy inhibitor Mdivi-1 was administered to OVX + MOX rats to determine the contribution of mitophagy to the effects of MOX.；Sequencing analysis and TargetScan prediction identified a potential regulatory relationship between miR-27a-3p and the mitophagy-related gene PINK1, which was subsequently validated using a dual-luciferase reporter assay. ‖ 结论：These effects may be mediated, at least in part, by activation of mitophagy through the BMSCs-associated miR-27a-3p/PINK1 axis, providing a potential mechanistic basis for the therapeutic effects of MOX in OP.
局限
未能获取全文，具体设计细节、失访与统计学处理无法核验。
对本项目的价值
★★★★★ 营养感知与自噬轴决定"干预窗口 + 剂量方案"，是组合疗法的时间锚。顶刊证据。
原文题录
- 英文标题：Mechanistic study on the promotion of osteogenic differentiation in osteoporotic rats by moxibustion via regulation of BMSCs-derived exosomal miR-27a-3p-mediated mitophagy.
- 期刊与标识：Cell Signal · PMID 42946315 · DOI 10.1016/j.cellsig.2026.112962**
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。